In the forecasted period from 2024 to 2028, the mortality rate for malignant neoplasms of the trachea, bronchus, or lung among females in Canada shows a steady increase, albeit at a minimal rate from 50.1 to 50.3 deaths per 100,000 women. The year-on-year variation is very slight, suggesting stability but with a slight upward trend. Assuming stability in actual data for 2023, the average compound annual growth rate (CAGR) over five years remains minimal, indicating almost stagnant mortality rates.
Future trends to watch for include advancements in medical interventions and public health initiatives aimed at reducing smoking and air pollution, which may impact these mortality rates, potentially leading to improved outcomes beyond 2028.
